American International Group, Inc. Oramed Pharmaceuticals Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $68,901 - $166,698	-18,522 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.19 - $13.89 $19,762 - $33,516	2,413 Added 14.98%	18,522 $160,000
Q4 2021 Feb 11, 2022	SELL	$12.98 - $29.75 $6,256 - $14,339	-482 Reduced 2.91%	16,109 $230,000
Q3 2021 Nov 12, 2021	BUY	$12.13 - $23.82 $19,674 - $38,636	1,622 Added 10.84%	16,591 $365,000
Q2 2021 Aug 13, 2021	BUY	$8.34 - $14.59 $124,841 - $218,397	14,969 New	14,969 $200,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.